시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
희귀질환 치료 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2031년)
Rare Disease Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
상품코드 : 1590361
리서치사 : Persistence Market Research
발행일 : 2024년 11월
페이지 정보 : 영문 283 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,995 ￦ 7,227,000
Unprintable PDF & Excel (Single User License) help
PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.
US $ 7,295 ￦ 10,555,000
PDF & Excel (Multi User License) help
PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.
US $ 8,495 ￦ 12,291,000
PDF & Excel (Corporate User License) help
PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

이 보고서는 세계 희귀질환 치료제 시장을 조사 분석하여 시장 성장 촉진요인, 동향, 기회, 과제 등 주요 시장 역학에 대한 평가와 시장 구조에 대한 상세한 통찰력을 제공합니다.

목차

제1장 주요 요약

제2장 시장 서론

제3장 시장 시점

제4장 북미의 희귀질환 치료 시장 분석과 예측

제5장 라틴아메리카의 희귀질환 치료 시장 분석과 예측

제6장 유럽의 희귀질환 치료 시장 분석과 예측

제7장 아시아태평양의 희귀질환 치료 시장 분석과 예측

제8장 중동 및 아프리카의 희귀질환 치료 시장 분석과 예측

제9장 경쟁 구도

제10장 세계의 희귀질환 치료 시장 분석과 예측 : 지역별

제11장 세계의 희귀질환 치료 시장 분석과 예측 : 치료 영역별, 거시경제 요인

제12장 세계의 희귀질환 치료 시장 분석과 예측 : 약제 유형별

제13장 세계의 희귀질환 치료 시장 분석과 예측 : 약제 클래스별

제14장 세계의 희귀질환 치료 시장 분석과 예측 : 투여 방법별

제15장 세계의 희귀질환 치료 시장 분석과 예측 : 유통 채널별

제16장 세계의 희귀질환 치료 시장 분석과 예측

제17장 조사 방법

LSH
영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the global Rare Disease Treatment Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

Rare Disease Treatment Market - Report Scope:

The Rare Disease Treatment market includes therapies and medicines designed to treat diseases that affect a small percentage of the population, known as orphan diseases. These treatments involve a wide array of medications, biologics, gene therapies, and specialized care regimens that address conditions such as hemophilia, cystic fibrosis, Duchenne muscular dystrophy, and rare cancers. The market is driven by advancements in biotechnology, increased government support, and growing patient awareness. With significant unmet needs in rare disease treatments, the market is expanding rapidly, attracting a surge of investment from pharmaceutical companies and biotech firms.

Market Growth Drivers:

Several key factors are driving the growth of the Rare Disease Treatment market, including advancements in gene therapies, biologics, and orphan drugs, which offer targeted treatments for rare diseases. Increasing government and regulatory body support for orphan drug development, including financial incentives, faster regulatory approvals, and exclusivity periods, has boosted market expansion. Moreover, growing awareness among healthcare providers and patients about rare diseases, coupled with the rise in personalized medicine, is fueling the demand for rare disease treatments. The increasing focus on precision medicine and cutting-edge technologies, including CRISPR and gene editing, is likely to further drive the market forward.

Market Restraints:

Despite its growth potential, the Rare Disease Treatment market faces several challenges, including high research and development costs, regulatory hurdles, and limited patient populations. The development of orphan drugs and treatments for rare diseases often involves significant financial investments and time, with no guarantee of return due to the small number of patients. Additionally, high treatment costs and limited insurance coverage for rare disease therapies pose barriers to widespread adoption. Moreover, logistical and distribution challenges related to the delivery of specialized treatments and drugs also limit market growth in certain regions.

Market Opportunities:

The Rare Disease Treatment market presents significant growth opportunities, particularly with the increasing prevalence of genetic and rare diseases, advancements in biotechnology, and rising awareness. The growing interest in gene therapies and personalized medicine offers substantial potential for innovation and market growth. Furthermore, the expansion of regulatory frameworks to support the development of orphan drugs, alongside rising investments from venture capital and public-private partnerships, is expected to propel the market forward. Strategic collaborations between biopharmaceutical companies, research institutions, and healthcare organizations are expected to lead to breakthroughs in rare disease treatments and the development of novel therapies.

Key Questions Answered in the Report:

Competitive Intelligence and Business Strategy:

Leading companies in the global Rare Disease Treatment market, including Novartis, Sanofi, and Vertex Pharmaceuticals, are focusing on innovation, strategic partnerships, and the expansion of their treatment portfolios to remain competitive. These companies are investing heavily in research and development to discover new therapies for rare diseases, including gene therapies and biologics. Collaborations with academic research institutions, healthcare providers, and government bodies are critical for accelerating drug development and overcoming regulatory challenges. Furthermore, focusing on expanding market access through patient assistance programs and improved healthcare infrastructure is key for sustaining growth in this sector.

Key Companies Profiled:

Rare Disease Treatment Industry Research by Category:

By Disease Type:

By Treatment Type:

By Distribution Channel:

By Region:

Table of Contents

1. Executive Summary

2. Market Introduction

3. Market View Point

4. North America Rare Disease Treatment Market Analysis 2019-2023 and Forecast 2024-2031

5. Latin America Rare Disease Treatment Market Analysis 2019-2023 and Forecast 2024-2031

6. Europe Rare Disease Treatment Market Analysis 2019-2023 and Forecast 2024-2031

7. APAC Rare Disease Treatment Market Analysis 2019-2023 and Forecast 2024-2031

8. MEA Rare Disease Treatment Market Analysis 2019-2023 and Forecast 2024-2031

9. Competition Landscape

10. Global Rare Disease Treatment Market Analysis 2019-2023 and Forecast 2024-2031, By Region

11. Global Rare Disease Treatment Market Analysis 2019-2023 and Forecast 2024-2031, By Therapeutic Area Macro-economic Factors

12. Global Rare Disease Treatment Market Analysis 2019-2023 and Forecast 2024-2031, By Drug Type

13. Global Rare Disease Treatment Market Analysis 2019-2023 and Forecast 2024-2031, By Drug Class

14. Global Rare Disease Treatment Market Analysis 2019-2023 and Forecast 2024-2031, By Mode of Administration

15. Global Rare Disease Treatment Market Analysis 2019-2023 and Forecast 2024-2031, By Distribution Channel

16. Global Rare Disease Treatment Market Analysis 2019-2023 and Forecast 2024-2031

17. Research Methodology

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기